Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/10 → 31/12/16 |
Collaborative partners
- University of Vienna
- Novartis Pharma AG (lead)
Publications
- 4 Article
-
Curated human hyperbilirubinemia data and the respective OATP1B1 and 1B3 inhibition predictions
Kotsampasakou, E., Escher, S. E. & Ecker, G. F., Apr 2017, In: Data in Brief. 11, p. 204-207 4 p.Publications: Contribution to journal › Article › Peer Reviewed
Open Access -
Legacy data sharing to improve drug safety assessment: the eTOX project
Sanz, F., Pognan, F., Steger-Hartmann, T., Díaz, C., Cases, M., Pastor, M., Marc, P., Wichard, J., Briggs, K., Watson, D. K., Kleinöder, T., Yang, C., Amberg, A., Beaumont, M., Brookes, A. J., Brunak, S., Cronin, M. T. D., Ecker, G. F., Escher, S. & Greene, N. & 16 others, , Dec 2017, In: Nature Reviews. Drug Discovery. 16, 12, p. 811-812 2 p.Publications: Contribution to journal › Article › Peer Reviewed
-
Predicting Drug-Induced Cholestasis with the Help of Hepatic Transporters-An in Silico Modeling Approach
Kotsampasakou, E. & Ecker, G. F., 27 Mar 2017, In: Journal of Chemical Information and Modeling. 57, 3, p. 608-615 8 p.Publications: Contribution to journal › Article › Peer Reviewed
Open Access
Activities
- 2 Talk or oral contribution
-
Transporter Informatics and Computational Toxicology - from QSAR to Machine Learning and beyond
Ecker, G. (Speaker)
7 Sept 2022Activity: Talks and presentations › Talk or oral contribution › Science to Science
-
In silico Toxicology - from prediction of transporter interaction profiles to toxicological read across and beyond
Ecker, G. (Invited speaker)
13 Mar 2018Activity: Talks and presentations › Talk or oral contribution › Science to Science